Identification of B cell epitopes recognized by antibodies specific for the tumor antigen NY-ESO-1 in cancer patients with spontaneous immune responses
- 31 October 2005
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 117 (1) , 24-30
- https://doi.org/10.1016/j.clim.2005.05.003
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Survey of naturally occurring CD4 + T cell responses against NY-ESO-1 in cancer patients: Correlation with antibody responsesProceedings of the National Academy of Sciences, 2003
- Differential presentation of a soluble exogenous tumor antigen, NY-ESO-1, by distinct human dendritic cell populationsProceedings of the National Academy of Sciences, 2002
- Fcγ Receptors and Cross-Presentation in Dendritic CellsThe Journal of Experimental Medicine, 2002
- CD4+T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: Association with NY-ESO-1 antibody productionProceedings of the National Academy of Sciences, 2001
- Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responsesProceedings of the National Academy of Sciences, 2000
- Humoral immune responses of cancer patients against “Cancer-Testis” antigen NY-ESO-1: Correlation with clinical eventsInternational Journal of Cancer, 1999
- Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cellsNature Cell Biology, 1999
- A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor AntigensThe Journal of Experimental Medicine, 1998
- Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide EpitopesThe Journal of Experimental Medicine, 1998
- A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screeningProceedings of the National Academy of Sciences, 1997